Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Asia
Asia
BMS buys Asian rights to key growth drug Camzyos
Pharmaphorum
Wed, 10/25/23 - 09:46 am
Bristol Myers Squibb
Asia
Camzyos
obstructive hypertrophic cardiomyopathy
Eisai files Leqembi in Korea, as US prospects firm up
Pharmaphorum
Thu, 06/8/23 - 10:02 am
Eisai
Biogen
Leqembi
Alzheimer's disease
South Korea
Asia
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Fierce Biotech
Thu, 08/18/22 - 12:40 pm
Astellas
menopause
FDA
clinical trials
Asia
fezolinetant
hot flashes
Merck KGaA launches Asia startup scheme to locate next generation of partnerships
Fierce Biotech
Fri, 07/15/22 - 10:52 am
Asia
Merck KGaA
startups
funding
Small RSV contender eyes 'first-to-market' opportunity with $225M Asia deal
Endpoints
Mon, 03/21/22 - 10:13 am
Bavarian Nordic
RSV
vaccines
Asia
Nuance Pharma
Kiniksa inks licensing deal to take a Regeneron castoff into Asian markets
Endpoints
Wed, 02/23/22 - 10:31 am
Kiniksa Pharmaceuticals
Regeneron
Arcalyst
Huadong Medicine
Asia
mavrilimumab
Covid-19 vaccine maker Moderna to set up subsidiary in Singapore as it boosts regional presence
Today Online, Singapore
Wed, 02/16/22 - 10:55 am
Moderna Therapeutics
Singapore
Asia
vaccines
COVID-19
2 Medtech Giants Are Working to Enhance Cardiac Care in Southeast Asia
Medical Devices and Diagnostics Industry
Wed, 01/5/22 - 10:43 pm
devices
Medtech
Asia
GE Healthcare
Boston Scientific
interventional cardiology
Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar
Pharmaceutical Business Review
Thu, 12/9/21 - 10:57 am
Prestige BioPharma
Dr Reddy's
trastuzumab
biosimilars
Latin American
Asia
Is Vaccine Latecomer Inovio Making a Comeback?
Motley Fool
Wed, 09/29/21 - 11:05 am
Inovio
vaccines
COVID-19
clinical trials
Africa
Latin America
Asia
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Fierce Biotech
Mon, 05/17/21 - 10:44 am
LianBio
Landos Biopharma
IPOs
ulcerative colitis
Crohn's Disease
China
Asia
Samsung Biologics and AstraZeneca launch strategic manufacturing partnership
Biopharma Reporter
Tue, 09/22/20 - 10:49 am
Samsung BioLogics
AstraZeneca
Asia
biologics
drug manufacturing
Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?
Motley Fool
Sun, 02/2/20 - 11:54 pm
Amgen
earnings
M&A
Asia
With Immunomedics ADC deal, Everest bolsters cancer pipeline
BioCentury
Mon, 04/29/19 - 08:50 pm
Immunomedics
sacituzumab govitecan
Everest Medicines
Asia
Ascletis Pharma, Asia’s first pre-profit listed biotech, plunges in Hong Kong three days after debut
South China Morning Post
Sun, 08/5/18 - 12:31 pm
Asia
Hong Kong
Ascletis
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
CP Wire
Fri, 07/13/18 - 11:55 am
AB928
Arcus Biosciences
Taiho Pharmaceutical
oncology
Asia
Japan
With the ink on their $25M Astellas deal still drying, Aquinox shares get blasted on PhIII failure
Endpoints
Wed, 06/27/18 - 10:21 am
Aquinox Pharmaceuticals
Astellas
rosiptor
Asia
clinical trials
Interstitial Cystitis
On a roll, Sage grabs a $575M deal on limited Asian rights to SAGE-217 — a potential gamechanger in depression
Endpoints
Wed, 06/13/18 - 09:48 pm
SAGE Therapeutics
SAGE-217
Asia
Shionogi
depression
Sound familiar? China/US biotech hybrid lands rights to cancer drugs, cash and a team of development vets to launch Oncologie
Endpoints
Fri, 06/8/18 - 11:34 pm
China
Asia
Oncologie
Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug
Fierce Biotech
Thu, 05/10/18 - 09:32 am
Astellas
Aquinox Pharmaceuticals
SHIP1 activator
Japan
Asia
rosiptor
Pages
1
2
3
4
next ›
last »